LPA and coronary artery disorder: Nowadays, there is very little scientific information about the levels of serum Lp(a) and PAI-1 in type 2 diabetes around the world, and it is also an important fact that both of them combine in one role, which is that they prevent fibrinolysis process, a risk factor for CAD.